phenobarbital has been researched along with Hyperlipoproteinemias in 1 studies
Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.
Hyperlipoproteinemias: Conditions with abnormally elevated levels of LIPOPROTEINS in the blood. They may be inherited, acquired, primary, or secondary. Hyperlipoproteinemias are classified according to the pattern of lipoproteins on electrophoresis or ultracentrifugation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fears, R | 1 |
| Rush, WR | 1 |
| Walker, P | 1 |
| Ferres, H | 1 |
1 other study available for phenobarbital and Hyperlipoproteinemias
| Article | Year |
|---|---|
Hyperalphalipoproteinaemic activity of BRL 26314--I. Enhanced cholesterol turnover in rats.
Topics: 1-Naphthylisothiocyanate; Animals; Bile Acids and Salts; Biological Transport; Cholestasis; Choleste | 1984 |